Audrey Sultan
Caen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Beyond gait speed: a multidimensional motor signature of motoric cognitive risk syndrome identified through domain-specific anomaly detection.
Journal: GeroScience
Published: May 07, 2026
Four months of treatment with anakinra combined with glucocorticoids for giant cell arteritis: a multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Arthritis research & therapy
Published: October 09, 2024
Whole-Country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A 7-Year Nationwide Database Analysis.
Journal: ACR open rheumatology
Published: January 17, 2022
Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis.
Journal: Journal of clinical medicine
Published: January 07, 2022
Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment Study.
Journal: Frontiers in medicine
Published: September 15, 2021
Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events.
Journal: Rheumatology (Oxford, England)
Published: August 02, 2021
Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertise.
Journal: Rheumatology (Oxford, England)
Published: December 21, 2020
Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control study.
Journal: Seminars in arthritis and rheumatism
Published: June 04, 2019
Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis.
Journal: Journal of autoimmunity
Published: February 26, 2019
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
Journal: The Journal of rheumatology
Published: February 20, 2019
Last Updated: 09/26/2026